Home › NDC Lookup › RxCUI directory › RxCUI 727762

5 ML fulvestrant 50 MG/ML Prefilled Syringe — RxCUI 727762

Name: 5 ML fulvestrant 50 MG/ML Prefilled Syringe (RxCUI 727762)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 727762 Semantic clinical drug · SCD ● Current RxNorm concept 26 FDA products 26 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI727762

Official name5 ML fulvestrant 50 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asfulvestrant 250 MG per 5 ML Prefilled Syringe; fulvestrant 250 MG in 5 ML Prefilled Syringe

FDA products mapped26

Package NDCs mapped26

Reported Medicaid activity (SDUD)8,707 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fulvestrant Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Fulvestrant injection is used to treat a specific type of advanced breast cancer — one that is hormone receptor-positive (meaning estrogen drives its growth) in postmenopausal wome...
What exactly is fulvestrant injection used for?
No — fulvestrant is an injection given by a nurse or doctor, usually into the muscle of your buttock. You'll come into the clinic or infusion center for it. The schedule starts wit...
How is this medicine given? Do I take it at home?

📖 Read our full Fulvestrant Injection guide →

🕸️ Concept Web — How 5 ML fulvestrant 50 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 5 ML fulvestrant 50 MG/ML Prefilled Syringe RxCUI 727762 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Fulvestrant 282357 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cligavyx 2745134 BN
- Faslodex 203870 BN
Dose forms 8

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Fulvestrant Prefilled Syringe 727760 SCDF
- Fulvestrant Injectable Product 1156671 SCDG
- Fulvestrant Prefilled Syringe [Cligavyx] 2745137 SBDF
- Fulvestrant Prefilled Syringe [Faslodex] 727953 SBDF
- Cligavyx Injectable Product 2745136 SBDG
- Faslodex Injectable Product 1174691 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Fulvestrant 50 MG/ML 350934 SCDC
- 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] 2745138 SBD
- 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex] 727954 SBD
- Fulvestrant 50 MG/ML [Cligavyx] 2745135 SBDC
- Fulvestrant 50 MG/ML [Faslodex] 575925 SBDC

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Fulvestrant 50 MG/ML SCDC · 350934
Fulvestrant Prefilled Syringe SCDF · 727760
Fulvestrant Injectable Product SCDG · 1156671

Brand-Name Concepts

5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] SBD · 2745138
5 ML fulvestrant 50 MG/ML Prefilled Syringe [Faslodex] SBD · 727954
Fulvestrant 50 MG/ML [Cligavyx] SBDC · 2745135
Fulvestrant 50 MG/ML [Faslodex] SBDC · 575925
Fulvestrant Prefilled Syringe [Cligavyx] SBDF · 2745137
Fulvestrant Prefilled Syringe [Faslodex] SBDF · 727953
Cligavyx Injectable Product SBDG · 2745136
Faslodex Injectable Product SBDG · 1174691
Cligavyx BN · 2745134
Faslodex BN · 203870

📦 FDA Products & Package NDCs

26 products · 26 package NDCs

26 package NDCs map to RxCUI 727762 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9022-02	2 SYRINGE, GLASS in 1 CARTON (0143-9022-02) / 5 mL in 1 SYR...	Fulvestrant	Hikma Pharmaceuticals USA Inc.	2022-02-10
00310-0720-10	2 SYRINGE, GLASS in 1 CARTON (0310-0720-10) / 5 mL in 1 SYR...	FASLODEX	AstraZeneca Pharmaceuticals LP	2010-11-01
00781-3532-12	2 SYRINGE, GLASS in 1 CARTON (0781-3532-12) / 5 mL in 1 SYR...	Fulvestrant	Sandoz Inc	2023-11-01
00781-9055-12	2 SYRINGE, GLASS in 1 CARTON (0781-9055-12) / 5 mL in 1 SYR...	Fulvestrant	Sandoz Inc	2023-07-01
16714-0070-02	2 SYRINGE, GLASS in 1 CARTON (16714-070-02) / 5 mL in 1 SYR...	FULVESTRANT	Northstar Rx, LLC,	2021-08-23
16729-0436-30	2 SYRINGE, GLASS in 1 CARTON (16729-436-30) / 5 mL in 1 SYR...	FULVESTRANT	Accord Healthcare Inc.	2021-01-21
25021-0471-66	2 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGE	fulvestrant	Sagent Pharmaceuticals	2026-04-15
25021-0471-74	2 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGE	fulvestrant	Sagent Pharmaceuticals	2024-09-15
43598-0262-23	2 SYRINGE, GLASS in 1 CARTON (43598-262-23) / 5 mL in 1 SYR...	Fulvestrant	Dr.Reddy's Laboratories Inc	2024-09-05
55150-0394-02	2 SYRINGE in 1 CARTON (55150-394-02) / 5 mL in 1 SYRINGE	Fulvestrant	Eugia US LLC	2023-06-30
62332-0650-10	2 SYRINGE in 1 CARTON (62332-650-10) / 5 mL in 1 SYRINGE (6...	Fulvestrant	Alembic Pharmaceuticals Inc.	2022-12-22
63323-0715-05	2 SYRINGE, GLASS in 1 CARTON (63323-715-05) / 5 mL in 1 SYR...	Fulvestrant	Fresenius Kabi USA, LLC	2019-05-20
68001-0484-85	2 SYRINGE, GLASS in 1 CARTON (68001-484-85) / 5 mL in 1 SYR...	Fulvestrant	BluePoint Laboratories	2021-03-01
68001-0522-85	2 SYRINGE, GLASS in 1 CARTON (68001-522-85) / 5 mL in 1 SYR...	FULVESTRANT	BluePoint Laboratories	2021-10-29
68001-0626-85	2 SYRINGE in 1 CARTON (68001-626-85) / 5 mL in 1 SYRINGE (6...	Fulvestrant	BluePoint Laboratories.	2025-01-17
68462-0317-32	2 SYRINGE, GLASS in 1 CARTON (68462-317-32) / 5 mL in 1 SYR...	Fulvestrant	GLENMARK PHARMACEUTICALS INC., USA	2019-08-22
70121-1463-02	2 SYRINGE, GLASS in 1 CARTON (70121-1463-2) / 5 mL in 1 SYR...	Fulvestrant	Amneal Pharmaceuticals LLC	2019-03-04
70121-1463-09	2 SYRINGE, GLASS in 1 CARTON (70121-1463-9) / 5 mL in 1 SYR...	Fulvestrant	Amneal Pharmaceuticals LLC	2025-06-03
70700-0284-98	2 SYRINGE, GLASS in 1 CARTON (70700-284-98) / 5 mL in 1 SYR...	FULVESTRANT	Xiromed, LLC	2021-08-19
70710-1688-08	2 SYRINGE, GLASS in 1 CARTON (70710-1688-8) / 5 mL in 1 SYR...	FULVESTRANT	Zydus Pharmaceuticals USA Inc.	2021-12-14
70771-1626-08	2 SYRINGE, GLASS in 1 CARTON (70771-1626-8) / 5 mL in 1 SYR...	FULVESTRANT	Zydus Lifesciences Limited	2021-12-14
70860-0211-74	2 SYRINGE, GLASS in 1 CARTON (70860-211-74) / 5 mL in 1 SYR...	Fulvestrant	Athenex Pharmaceutical Division, LLC.	2020-02-18
71288-0555-86	2 SYRINGE in 1 CARTON (71288-555-86) / 5 mL in 1 SYRINGE (7...	Fulvestrant	Meitheal Pharmaceuticals Inc	2019-11-21
71731-6121-01	2 SYRINGE, GLASS in 1 CARTON (71731-6121-1) / 5 mL in 1 SYR...	Fulvestrant	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	2021-04-01
83634-0203-74	2 SYRINGE, GLASS in 1 CARTON (83634-203-74) / 5 mL in 1 SYR...	Fulvestrant	Avenacy, Inc.	2024-02-28
83831-0159-02	2 SYRINGE, GLASS in 1 CARTON (83831-159-02) / 5 mL in 1 SYR...	CLIGAVYX	Avyxa Pharma, LLC	2026-07-01

Observed labelers: Amneal Pharmaceuticals LLC (2) · BluePoint Laboratories (2) · Sagent Pharmaceuticals (2) · Sandoz Inc (2) · Accord Healthcare Inc. (1) · Alembic Pharmaceuticals Inc. (1) · +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9395	Injection, fulvestrant	19	CMS
J9394	Inj, fulvestrant (fresenius)	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.